The estimated Net Worth of Richard D Luzzi is at least 31.3 百万$ dollars as of 27 February 2015. Mr Luzzi owns over 10,000 units of West Pharmaceutical Services stock worth over 30,453,599$ and over the last 19 years he sold WST stock worth over 857,580$.
Mr has made over 7 trades of the West Pharmaceutical Services stock since 2012, according to the Form 4 filled with the SEC. Most recently he exercised 10,000 units of WST stock worth 208,500$ on 27 February 2015.
The largest trade he's ever made was exercising 38,708 units of West Pharmaceutical Services stock on 4 November 2013 worth over 553,137$. On average, Mr trades about 1,907 units every 16 days since 2005. As of 27 February 2015 he still owns at least 100,723 units of West Pharmaceutical Services stock.
You can see the complete history of Mr Luzzi stock trades at the bottom of the page.
Richard D. Luzzi is the Sr. VP of HR at West Pharmaceutical Services.
Mr Luzzi is 69, he's been the Sr. VP of HR of West Pharmaceutical Services since . There are 1 older and 25 younger executives at West Pharmaceutical Services. The oldest executive at West Pharmaceutical Services, Inc. is Patrick Zenner, 73, who is the Independent Chairman of the Board.
Richard's mailing address filed with the SEC is 101 GORDON DRIVE, , LIONVILLE, PA, 19341.
Over the last 19 years, insiders at West Pharmaceutical Services have traded over 32,829,857$ worth of West Pharmaceutical Services stock and bought 19,924 units worth 1,139,950$ . The most active insiders traders include Robert F Friel、Paolo Pucci、Douglas A Michels. On average, West Pharmaceutical Services executives and independent directors trade stock every 40 days with the average trade being worth of 4,786,805$. The most recent stock trade was executed by Charles Witherspoon on 19 August 2024, trading 1,029 units of WST stock currently worth 308,700$.
west works side-by-side with healthcare partners from concept to the patient, designing and manufacturing packaging and delivery systems that promote efficiency, reliability and safety. west leads the way with cutting-edge technologies and quality systems, a thorough understanding of global regulatory compliance, and an unmatched knowledge of relevant pharmaceutical product testing, development and packaging. west supports customers from sales, manufacturing, and research and development locations in north and south america, europe, asia and australia.
West Pharmaceutical Services executives and other stock owners filed with the SEC include: